Related Experiment Video
Updated: Jun 12, 2025

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
Published on: May 13, 2022
A framework for multi-scale intervention modeling: virtual cohorts, virtual clinical trials, and model-to-model
Christian T Michael1,2, Sayed Ahmad Almohri2, Jennifer J Linderman2
1Department of Microbiology & Immunology, University of Michigan - Michigan Medicine, Ann Arbor, MI, USA.
A new multi-scale interventional design (MID) framework tracks disease and intervention impacts from cellular to population levels. This computational approach, applied to tuberculosis (TB), reveals patient-specific factors influencing treatment efficacy across scales.
Area of Science:
- Computational biology
- Systems biology
- Informatics
Background:
- Computational models for disease progression are common, but in-silico intervention studies often lack standardized design.
- Existing approaches frequently mimic experimental study designs, limiting their scope for multi-scale analysis.
- Tracking disease dynamics and intervention effects across different scales (e.g., cellular, patient, population) remains a challenge.
Purpose of the Study:
- To introduce a novel Multi-scale Interventional Design (MID) framework for computational disease modeling.
- To enable tracking of disease dynamics and intervention impacts across within-body, patient, and population scales.
- To prioritize the investigation of intervention impacts on individual patients within virtual pre-clinical trials.
Main Methods:
- Applied the MID framework to develop and analyze a cohort of virtual patients using the HostSim computational model.
- HostSim models Mycobacterium tuberculosis infection, including lung granulomas, blood, and lymph node compartments.
- Integrated a drug intervention into HostSim and utilized the MID framework to quantify treatment impact across cellular, tissue, patient, and population scales.
Main Results:
- The MID framework successfully quantified the impact of a drug intervention on tuberculosis at multiple scales.
- Sensitivity analyses identified key virtual patient features predicting intervention efficacy across scales.
- Identified patient-heterogeneous mechanisms driving outcomes across different scales.
Conclusions:
- The MID framework provides a robust approach for in-silico intervention studies, offering insights into multi-scale disease dynamics.
- This framework facilitates the identification of patient-specific factors influencing treatment response in silico.
- The study demonstrates the utility of MID and HostSim for understanding tuberculosis progression and intervention effects.
Related Concept Videos
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Statistical Software for Data Analysis and Clinical Trials
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

